Summary: The fiscal year 2025 (FY25) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD). Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.

Distinctive Features: The FY25 DMDRP IDA mechanism has a New Investigator category for applicants early in their careers (i.e., within 10 years of their first faculty appointment or equivalent) or for established investigators new to DMD research.

• The New Investigator – Early Stage category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators.

• The New Investigator – Transitioning category is designed for investigators in an area other than muscular dystrophy, at or above the level of Assistant Professor, seeking to transition to a career in DMD, thereby bringing their expertise to the field.

Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required.

Miscellaneous

• Unrestricted